C9497 HCPCS Level II Code: Loxapine, inhalation powder, 10 mg
Coding at a Glance
- CMS cross-references
- 1 related code
Medicare Coverage & Payment
- CMS short descriptor: Loxapine, inhalation powder
- Medicare coverage: Special coverage instructions apply (CMS coverage code D)
- Pricing indicator: 53
- BETOS: O1E — Other drugs
- Last CMS action effective: January 1, 2019
- Terminated: December 31, 2018
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Code Set: Removed from the code set — not valid on or after January 1, 2019.
Related Codes
CMS cross-reference: code to use instead
The CMS HCPCS Level II code set carries an explicit cross-reference from this code (deleted or not valid for Medicare) to this code. A cross-referenced code can itself have been retired since; a terminated target is marked.
Contextual Map
Every relationship of C9497 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (40)
- C9455 — Injection, siltuximab, 10 mg[Sibling]— CMS HCPCS Level II code set
- C9456 — Injection, isavuconazonium sulfate, 1 mg[Sibling]— CMS HCPCS Level II code set
- C9457 — Injection, sulfur hexafluoride lipid microsphere, per ml[Sibling]— CMS HCPCS Level II code set
- C9458 — Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries[Sibling]— CMS HCPCS Level II code set
- C9459 — Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries[Sibling]— CMS HCPCS Level II code set
- C9460 — Injection, cangrelor, 1 mg[Sibling]— CMS HCPCS Level II code set
- C9461 — Choline c 11, diagnostic, per study dose[Sibling]— CMS HCPCS Level II code set
- C9462 — Injection, delafloxacin, 1 mg[Sibling]— CMS HCPCS Level II code set
- and 32 more
CMS cross-reference
- J2062 — Loxapine for inhalation, 1 mg[Cross-referenced to]— CMS HCPCS Level II code set (cross-reference field) · JUL2026
Change history (2)
- January 1, 2019 — Removed from the code set [Change history]— CMS release files (code change ledger)
- and 1 more
Sources for this page
Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.
- Code, descriptors, coverage and pricing attributes Official source data
- CMS HCPCS Alpha-Numeric (ANWEB) release — July 2026 quarterly update Release, file and checksum · Publisher’s page
- Change history and date-of-service validity Official source data
- CMS HCPCS quarterly update files, ingested into the change ledger Release, file and checksum · Publisher’s page
- Comparisons, relationships and the contextual map MedCoder structured relationship
- Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
- Summary and FAQ answers MedCoder explanation
- Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.
Labels on this page: Official source data · MedCoder structured relationship · MedCoder explanation. How to read the labels · All data sources and release dates
Change history
- January 1, 2019Removed from the code setLoxapine, inhalation powder, 10 mg
- January 1, 2014Added to the code setLoxapine, inhalation powder, 10 mg
Nearest Codes in This Family
Official HCPCS Level II classifications closest to C9497 in its code family, with their registry titles.
- C9485 — Injection, olaratumab, 10 mg
- C9486 — Injection, granisetron extended release, 0.1 mg
- C9487 — Ustekinumab, for intravenous injection, 1 mg
- C9488 — Injection, conivaptan hydrochloride, 1 mg
- C9489 — Injection, nusinersen, 0.1 mg
- C9490 — Injection, bezlotoxumab, 10 mg
- C9491 — Injection, avelumab, 10 mg
- C9492 — Injection, durvalumab, 10 mg
- C9493 — Injection, edaravone, 1 mg
- C9494 — Injection, ocrelizumab, 1 mg